You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for PYLORI-CHEK BREATH TEST


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PYLORI-CHEK BREATH TEST

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 299359_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 603430_ALDRICH ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-929-552 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for PYLORI-CHEK BREATH TEST

Last updated: November 14, 2025

Introduction

The detection and management of Helicobacter pylori (H. pylori) infection remain critical in gastrointestinal health. The PYLORI-CHEK Breath Test is a non-invasive diagnostic tool widely used by healthcare practitioners to identify active H. pylori infections. Central to the efficacy and reliability of this diagnostic assay is the quality of the Active Pharmaceutical Ingredient (API) utilized in its reagent components. This article explores the primary sources of bulk APIs relevant for the PYLORI-CHEK Breath Test, the supply chain considerations, and industry best practices in sourcing high-quality materials.

The Role of API in PYLORI-CHEK Breath Testing

The PYLORI-CHEK Breath Test functions by administering a urea labeled with an isotope, typically carbon-13 (13C) or carbon-14 (14C), which is metabolized by the H. pylori bacteria, releasing labeled carbon dioxide detectable in the patient's breath. The API, in this context, is the labeled urea compound that initiates the enzymatic reaction.

Ensuring high purity and stable isotope labeling of the API is vital for test accuracy. Variability in API quality can lead to false positives or negatives, undermining diagnostic reliability. Therefore, sourcing APIs from reputable manufacturers with proven quality management systems is essential.

Key API Components for PYLORI-CHEK

  1. Labeled Urea (13C or 14C)

    • The primary API in the breath test reagent.
    • Must be isotopically enriched and chemically pure.
    • Stability and bioavailability are critical for accurate results.
  2. Supporting Reagents

    • May include buffers, stabilizers, and preservatives, often sourced from different suppliers.

Between these, the focus of this discussion is on the bulk API of labeled urea, especially the isotopically labeled forms.

Major Sources of API for PYLORI-CHEK Breath Test

1. Global API Manufacturers Specializing in Isotope Labeling

Several companies globally supply high-purity, isotopically labeled urea:

  • Cambridge Isotope Laboratories (CIL)
    A leading supplier, offering 13C-labeled urea of pharmaceutical or laboratory-grade purity. CIL’s comprehensive catalog includes isotopic enrichment levels up to 99% and custom synthesis options. Their stringent quality control ensures consistent isotopic labeling and chemical purity, making them a preferred supplier for diagnostic manufacturers ([1]).

  • Sigma-Aldrich (Merck Group)
    Provides 13C-Urea and other labeled compounds used extensively in research and diagnostic kits. Sigma maintains rigorous GMP standards and offers certificates of analysis detailing isotopic purity and residual impurities. Their global distribution network ensures timely supply.

  • IsoSciences LLC
    Specializes in custom isotope synthesis, including 13C-labeled urea, for medical and pharmaceutical applications. Their focus on purity and stability makes them an ideal source for diagnostic APIs requiring high isotopic enrichment.

2. Regional API Suppliers and Contract Manufacturing Organizations (CMOs)

While global leaders dominate the market, regional providers often cater to specific markets:

  • Wellington Laboratories
    Offers a range of labeled compounds, including specialty isotopes with guaranteed high purity and regulatory compliance.

  • CordenPharma
    Provides custom synthesis and manufacturing of labeled pharmaceuticals and APIs, often collaborating with diagnostic companies for bespoke formulations.

3. Emerging Suppliers and Natural Sources

Although less common, some emerging firms focus on bio-engineered or natural sources of isotopically labeled compounds, often at lower costs but with variable quality. Sourcing from these providers requires meticulous qualification and validation processes.

Supply Chain Considerations

Successfully procuring bulk APIs for PYLORI-CHEK Breath Tests necessitates addressing key supply chain aspects:

  • Regulatory Compliance: Suppliers must meet international standards such as Good Manufacturing Practice (GMP), especially if API materials are directly incorporated into diagnostic kits for clinical use.

  • Quality Assurance & Validation: Certificates of Analysis (CoA), isotopic purity, residual solvents, heavy metals, and microbial limits documentation are essential to validate API quality.

  • Stability & Storage: APIs should demonstrate stability over projected shelf life under specified storage conditions, minimizing degradation that could impact test accuracy.

  • Lead Times and Supply Security: Reliable supplies with contingency plans mitigate disruptions that could affect production schedules.

Industry Best Practices for API Sourcing

  • Vendor Qualification: Rigorously qualify suppliers based on their quality systems, past performance, and compliance history.
  • Batch Traceability: Maintain detailed records for traceability of each API batch, supporting quality control and regulatory audits.
  • Analytical Validation: Conduct in-house testing to verify isotopic enrichment and chemical purity before integration into diagnostic kits.
  • Regulatory Engagement: Collaborate with regulatory authorities to align sourcing practices with clinical and pharmaceutical requirements.

Summary

The production of reliable PYLORI-CHEK breath tests hinges critically on sourcing high-quality, isotopically labeled urea APIs. Leading global API manufacturers such as Cambridge Isotope Laboratories, Sigma-Aldrich, and IsoSciences dominate this niche, offering high-purity, GMP-compliant compounds. Regional and emerging suppliers may provide alternative options but necessitate comprehensive qualification.

Industry best practices in vendor qualification, validation, and supply chain management are instrumental in maintaining test accuracy, regulatory compliance, and product consistency.


Key Takeaways

  • The core API for PYLORI-CHEK breath testing is labeled urea (13C or 14C), requiring high isotopic purity and chemical integrity.
  • Leading global suppliers like Cambridge Isotope Laboratories and Sigma-Aldrich are preferred sources, offering quality assurance and reliable supply chains.
  • Proper qualification, validation, and adherence to GMP standards in sourcing APIs are critical to ensuring test accuracy and regulatory compliance.
  • Supply chain resilience, including contingency planning and detailed documentation, safeguards against disruptions impacting diagnostic production.
  • Industry best practices emphasize thorough vendor qualification, batch traceability, and rigorous analytical validation to uphold quality standards.

FAQs

1. What is the significance of isotopic purity in the API used for PYLORI-CHEK breath tests?
Isotopic purity directly impacts the sensitivity and specificity of the breath test. High isotopic enrichment ensures accurate detection of labeled CO₂ in the patient's breath, reducing false results.

2. Are there approved regulatory standards for sourcing APIs for diagnostic kits like PYLORI-CHEK?
Yes, APIs must comply with GMP standards, and suppliers should provide certifications demonstrating adherence to relevant pharmacopeial and regulatory requirements, such as FDA and EMA guidelines.

3. Can regional API suppliers meet the quality requirements for diagnostic applications?
While some regional suppliers can meet quality standards, rigorous qualification and validation processes are essential to verify that their products meet the strict purity and stability requirements for clinical diagnostics.

4. How do supply chain disruptions impact the production of breath test kits?
Supply chain disruptions can delay API procurement, affecting manufacturing schedules, inventory levels, and ultimately, patient access to timely diagnostics. Strategic sourcing and supplier diversification mitigate these risks.

5. Are there alternatives to isotopically labeled urea in H. pylori breath testing?
Currently, isotopically labeled urea remains the gold standard for non-invasive H. pylori detection due to its safety, accuracy, and non-radioactive nature (in the case of 13C). Alternatives lack comparable reliability or are unsuitable for clinical diagnostics.


References

[1] Cambridge Isotope Laboratories. Product Catalog – Isotope-labeled Urea. Available at: https://cll.com.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.